USPTO Is Rejecting Potentially Life-Saving Inventions

Patent law is generally not part of today’s public conversation. The issues don’t usually tug at our hearts, and the most hotly contested debates are both legally and technically intricate. But there is one issue that deserves the public’s attention now.

Beginning in 2012, the U.S. Supreme Court issued three decisions that radically limited the type of inventions that may be patented under § 101 of the patent laws: Mayo v. Prometheus, Association for Molecular Pathology v. Myriad Genetics and Alice v. CLS Bank.[1] Although these...

Already a subscriber? Click here to view full article